Anti-Lipoprotein Lipase Antibody as a Useful Marker for Plaque Vulnerability in Patients with Stable Angina
-
Published:2024-07-01
Issue:7
Volume:31
Page:1087-1097
-
ISSN:1340-3478
-
Container-title:Journal of Atherosclerosis and Thrombosis
-
language:en
-
Short-container-title:JAT
Author:
Yoshinaga Miyu1, Yuasa Eika1, Matsuoka Tetsuro2, Kihara Shinji1, Yamamoto Hiroyasu1
Affiliation:
1. Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine 2. Department of Cardiology, Hyogo Prefectural Nishinomiya Hospital
Publisher
Japan Atherosclerosis Society
Reference43 articles.
1. 1) Gaggini M, Gorini F and Vassalle C: Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia. Int J Mol Sci, 2022; 24: 2. 2) Linton MF, Yancey PG, Davies SS, Jerome WG, Linton EF, Song WL, Doran AC and Vickers KC: The Role of Lipids and Lipoproteins in Atherosclerosis. In: Endotext, ed by Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrere B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, and Wilson DP, South Dartmouth (MA), 2000 3. 3) Herrington W, Lacey B, Sherliker P, Armitage J and Lewington S: Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. Circ Res, 2016; 118: 535-546 4. 4) Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y, Fowkes FGR, Fowkes FJI and Rudan I: Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health, 2020; 8: e721-e729 5. 5) Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J and investigators A: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet, 2003; 361: 1149-1158
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|